Therapeutic delivery of nucleic acids for skin wound healing

References

• 1. Tobin DJ. Biochemistry of human skin – our brain on the outside. Chem. Soc. Rev. 35(1), 52–67 (2006).
  Medline CASGoogle Scholar
• 2. Kanitakis Jean. Anatomy, histology and immunohistochemistry of normal human skin. Eur. J. Dermatol. 12(4), 390–401 (2002).
  MedlineGoogle Scholar
• 3. Banerjee J, Sen CK. MicroRNAs in skin and wound healing. Methods Mol. Biol. 936, 343–356 (2013).
  Medline CASGoogle Scholar
• 4. Smyth Templeton N. Gene and Cell Therapy: Therapeutic Mechanisms and Strategies. (4th Edition). CRC Press (2015).
  Google Scholar
• 5. Mulholland EJ, Dunne N, McCarthy HO. MicroRNA as therapeutic targets for chronic wound healing. Mol. Ther. Nucleic Acids 8, 46–55 (2017).
  Medline CASGoogle Scholar
• 6. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature 453(7193), 314–321 (2008).
  Medline CASGoogle Scholar
• 7. Reinke JM, Sorg H. Wound repair and regeneration. ESR 49(1), 35–43 (2012).
  Medline CASGoogle Scholar
• 8. Berger AG, Chou JJ, Hammond PT. Approaches to modulate the chronic wound environment using localized nucleic acid delivery. Adv. Wound Care (2020).
  Google Scholar
• 9. Schultz GS, Chin GA, Moldawer L, Diegelmann RF. Principles of Wound Healing. University of Adelaide Press, Adelaide, Australia (2011).
  Google Scholar
• 10. Gailit J, Clark RAF. Wound repair in the context of extracellular matrix. Curr. Opin. Cell Biol. 6(5), 717–725 (1994).
  Medline CASGoogle Scholar
• 11. Bennett NT, Schultz GS. Growth factors and wound healing: part II. Role in normal and chronic wound healing. Am. J. Surg. 166(1), 74–81 (1993).
  Medline CASGoogle Scholar
• 12. Bennett NT, Schultz GS. Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am. J. Surg. 165(6), 728–737 (1993).
  Medline CASGoogle Scholar
• 13. Rumalla VK, Borah GL. Cytokines, growth factors, and plastic surgery. Plast. Reconstr. Surg. 108(3), 719–733 (2001).
  Medline CASGoogle Scholar
• 14. Meszaros AJ, Reichner JS, Albina JE. Macrophage-induced neutrophil apoptosis. J. Immunol. 165(1), 435–441 (2000).
  Medline CASGoogle Scholar
• 15. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8(12), 958–969 (2008).
  Medline CASGoogle Scholar
• 16. Mustoe TA, O'Shaughnessy K, Kloeters O. Chronic wound pathogenesis and current treatment strategies: a unifying hypothesis. Plast. Reconstr. Surg. 117(Suppl. 7), S35–S41 (2006).
  Google Scholar
• 17. El-Sherbiny IM, Yacoub MH. Hydrogel scaffolds for tissue engineering: progress and challenges. Glob. Cardiol. Sci. Pract. 2013(3), 38 (2013).
  Google Scholar
• 18. Lipsky BA, Hoey C. Topical antimicrobial therapy for treating chronic wounds. Clin. Infect. Dis. 49(10), 1541–1549 (2009).
  MedlineGoogle Scholar
• 19. Draelos ZD, Rizer RL, Trookman NS. A comparison of postprocedural wound care treatments: do antibiotic-based ointments improve outcomes? J. Am. Acad. Dermatol. 64(Suppl. 3), S23–S29 (2011).
  Medline CASGoogle Scholar
• 20. Newton DJ, Khan F, Belch JJF, Mitchell MR, Leese GP. Blood flow changes in diabetic foot ulcers treated with dermal replacement therapy. J. Foot Ankle Surg. 41(4), 233–237 (2002).
  Medline CASGoogle Scholar
• 21. Kirby J. Hyperbaric oxygen therapy and negative pressure as advanced wound management. Mol. Med. 116(3), 192–194 (2019).
  Google Scholar
• 22. Olsson M, Järbrink K, Divakar U et al. The humanistic and economic burden of chronic wounds: a systematic review. Wound Repair Regen. 27(1), 114–125 (2019).
  MedlineGoogle Scholar
• 23. Deonarine K, Panelli MC, Stashower ME et al. Gene expression profiling of cutaneous wound healing. J. Transl. Med. 5(1), 11 (2007).
  MedlineGoogle Scholar
• 24. Berger AG, Chou JJ, Hammond PT. Approaches to modulate the chronic wound environment using localized nucleic acid delivery. Adv. Wound Care 10, 503–528 (2020).
  Google Scholar
• 25. Aoki M, Miyake K, Ogawa R et al. siRNA knockdown of tissue inhibitor of metalloproteinase-1 in keloid fibroblasts leads to degradation of collagen type I. J. Invest. Dermatol. 134(3), 818–826 (2014).
  Medline CASGoogle Scholar
• 26. Monaghan M, Browne S, Schenke-Layland K, Pandit A. A collagen-based scaffold delivering exogenous microRNA-29B to modulate extracellular matrix remodeling. Mol. Ther. 22(4), 786–796 (2014).
  Medline CASGoogle Scholar
• 27. Spies M, Nesic O, Barrow RE, Perez-Polo JR, Herndon DN. Liposomal IGF-1 gene transfer modulates pro- and anti-inflammatory cytokine mRNA expression in the burn wound. Gene Ther. 8(18), 1409–1415 (2001).
  Medline CASGoogle Scholar
• 28. Wang X, Coradin T, Hélary C. Modulating inflammation in a cutaneous chronic wound model by IL-10 released from collagen–silica nanocomposites via gene delivery. Biomater. Sci. 6(2), 398–406 (2018).
  Medline CASGoogle Scholar
• 29. Kim HS, Yoo HS. In vitro and in vivo epidermal growth factor gene therapy for diabetic ulcers with electrospun fibrous meshes. Acta Biomater. 9(7), 7371–7380 (2013).
  Medline CASGoogle Scholar
• 30. Chai J, Baatar D, Tarnawski A. Serum response factor promotes re-epithelialization and muscular structure restoration during gastric ulcer healing. Gastroenterology 126(7), 1809–1818 (2004).
  Medline CASGoogle Scholar
• 31. Luo J-D, Wang Y-Y, Fu W-L, Wu J, Chen AF. Gene therapy of endothelial nitric oxide synthase and manganese superoxide dismutase restores delayed wound healing in Type 1 diabetic mice. Circulation 110(16), 2484–2493 (2004).
  Medline CASGoogle Scholar
• 32. Koyama T, Hackl F, Aflaki P et al. A new technique of ex vivo gene delivery of VEGF to wounds using genetically modified skin particles promotes wound angiogenesis. J. Am. Coll. Surg. 212(3), 340–348 (2011).
  MedlineGoogle Scholar
• 33. Waddington SN, Crossley R, Sheard V et al. Gene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous wounding. Mol. Ther. 18(12), 2104–2111 (2010).
  Medline CASGoogle Scholar
• 34. Shaterian A, Kao S, Chen L et al. The candidate tumor suppressor gene Ecrg4 as a wound terminating factor in cutaneous injury. Arch. Dermatol. Res. 305(2), 141–149 (2013).
  Medline CASGoogle Scholar
• 35. Wang C, Ma L, Gao C. Design of gene-activated matrix for the repair of skin and cartilage. Polym. J. 46(8), 476–482 (2014).
  CASGoogle Scholar
• 36. Sosnowski BK, Engler R, Chandler LA. Developing a gene-activated matrix product for chronic wounds: a biotech's perspective. In: Advances in Wound Care: Volume 1 Mary Ann Liebert, Inc., NY, USA (2010).
  Google Scholar
• 37. Sousa F, Passarinha L, Queiroz JA. Biomedical application of plasmid DNA in gene therapy: a new challenge for chromatography. Biotechnol. Genet. Eng. Rev. 26, 83–116 (2010).
  Medline CASGoogle Scholar
• 38. Sun L, Xu L, Chang H et al. Transfection with aFGF cDNA improves wound healing. J. Invest. Dermatol. 108(3), 313–318 (1997).
  Medline CASGoogle Scholar
• 39. Wolff JA, Malone RW, Williams P et al. Direct gene transfer into mouse muscle in vivo. Science 247(4949 Pt 1), 1465–1468 (1990).
  Medline CASGoogle Scholar
• 40. DeWeerdt S. RNA therapies explained. Nature 574(7778), S2–S3 (2019).
  CASGoogle Scholar
• 41. Khalil AS, Yu X, Umhoefer JM et al. Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins. Sci. Adv. 6(27), eaba2422 (2020).
  Medline CASGoogle Scholar
• 42. Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim. Biophys. Acta Mol. Cell Res. 1803(11), 1231–1243 (2010).
  CASGoogle Scholar
• 43. Yi R, O'Carroll D, Pasolli HA et al. Morphogenesis in skin is governed by discrete sets of differentially expressed microRNAs. Nat. Genet. 38(3), 356–362 (2006).
  Medline CASGoogle Scholar
• 44. Sen CK, Roy S. microRNA in cutaneous wound healing. In: Current Perspectives in microRNAs (miRNA). Ying S-Y (Ed.). Springer, Dordrecht, The Netherlands (2008).
  Google Scholar
• 45. Dana H, Chalbatani GM, Mahmoodzadeh H et al. Molecular mechanisms and biological functions of siRNA. Int. J. Biomed. Sci. 13(2), 48–57 (2017).
  MedlineGoogle Scholar
• 46. Meuli M, Liu Y, Liggitt D et al. Efficient gene expression in skin wound sites following local plasmid injection. J. Invest. Dermatol. 116(1), 131–135 (2001).
  Medline CASGoogle Scholar
• 47. Préat V, Dujardin N. Topical delivery of nucleic acids in the skin. STP Pharm. Sci. 11(1), 57 (2001).
  CASGoogle Scholar
• 48. Nayerossadat N, Maedeh T, Ali PA. Viral and nonviral delivery systems for gene delivery. Adv. Biomed. Res. 1, 27 (2012).
  MedlineGoogle Scholar
• 49. Cevher E, Sezer AD, Çağlar EŞ. Gene delivery systems: recent progress in viral and non-viral therapy. Recent Advances in Novel Drug Delivery Carrier Systems. Sezer AD (Ed.). IntechOpen, London, UK (2012).
  Google Scholar
• 50. Park Jc, Terry Mj, Man Lx et al. 152 retroviral gene therapy with the gene for PDGF-B promotes wound healing in diabetic mice. Wound Repair Regen. 13(2), A28–A48 (2005).
  Google Scholar
• 51. Stoff A, Rivera AA, Banerjee NS et al. Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen. 14(5), 608–617 (2006).
  MedlineGoogle Scholar
• 52. Vranckx JJ, Yao F, Petrie N et al. In vivo gene delivery of Ad-VEGF121 to full-thickness wounds in aged pigs results in high levels of VEGF expression but not in accelerated healing. Wound Repair Regen. 13(1), 51–60 (2005).
  MedlineGoogle Scholar
• 53. Glorioso JC, Goins WF, Schmidt MC et al. Engineering herpes simplex virus vectors for human gene therapy. Adv. Pharmacol. 40, 103–136 (1997).
  Medline CASGoogle Scholar
• 54. Badillo AT, Chung S, Zhang L, Zoltick P, Liechty KW. Lentiviral gene transfer of SDF-1alpha to wounds improves diabetic wound healing. J. Surg. Res. 143(1), 35–42 (2007).
  Medline CASGoogle Scholar
• 55. Zhu L, Mahato RI. Lipid and polymeric carrier-mediated nucleic acid delivery. Expert Opin. Drug Deliv. 7(10), 1209–1226 (2010).
  Medline CASGoogle Scholar
• 56. Chuan D, Jin T, Fan R, Zhou L, Guo G. Chitosan for gene delivery: methods for improvement and applications. Adv. Colloid Interface Sci. 268, 25–38 (2019).
  MedlineGoogle Scholar
• 57. Lungwitz U, Breunig M, Blunk T, Göpferich A. Polyethylenimine-based non-viral gene delivery systems. Eur. J. Pharm. Biopharm. 60(2), 247–266 (2005).
  Medline CASGoogle Scholar
• 58. Chauhan A. Dendrimers for drug delivery. Molecules 23(4), 938 (2018). www.mdpi.com/1420-3049/23/4/938
  MedlineGoogle Scholar
• 59. Benizri S, Gissot A, Martin A, Vialet B, Grinstaff MW, Barthélémy P. Bioconjugated Oligonucleotides: Recent Developments and Therapeutic Applications. Bioconjug. Chem. 30(2), 366–383 (2019).
  Medline CASGoogle Scholar
• 60. Shepard JA, Wesson PJ, Wang CE et al. Gene therapy vectors with enhanced transfection based on hydrogels modified with affinity peptides. Biomaterials 32(22), 5092–5099 (2011).
  Medline CASGoogle Scholar
• 61. Shin S, Tuinstra HM, Salvay DM, Shea LD. Phosphatidylserine immobilization of lentivirus for localized gene transfer. Biomaterials 31(15), 4353–4359 (2010).
  Medline CASGoogle Scholar
• 62. Shin S, Salvay DM, Shea LD. Lentivirus delivery by adsorption to tissue engineering scaffolds. J. Biomed. Mater. Res. A 93(4), 1252–1259 (2010).
  MedlineGoogle Scholar
• 63. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC. Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat. Genet. 10(2), 161–166 (1995).
  Medline CASGoogle Scholar
• 64. Eriksson E, Yao F, Svensjö T et al. In vivo gene transfer to skin and wound by microseeding. J. Surg. Res. 78(2), 85–91 (1998).
  Medline CASGoogle Scholar
• 65. Eming SA, Whitsitt JS, He L, Krieg T, Morgan JR, Davidson JM. Particle-mediated gene transfer of PDGF isoforms promotes wound repair. J. Invest. Dermatol. 112(3), 297–302 (1999).
  Medline CASGoogle Scholar
• 66. Jeschke MG, Richter G, Herndon DN et al. Therapeutic success and efficacy of nonviral liposomal cDNA gene transfer to the skin in vivo is dose dependent. Gene Ther. 8(23), 1777–1784 (2001).
  Medline CASGoogle Scholar
• 67. Doukas J, Chandler LA, Gonzalez AM et al. Matrix immobilization enhances the tissue repair activity of growth factor gene therapy vectors. Hum. Gene Ther. 12(7), 783–798 (2001).
  Medline CASGoogle Scholar
• 68. Schwarz KW, Murray MT, Sylora R, Sohn RL, Dulchavsky SA. Augmentation of wound healing with translation initiation factor eIF4E mRNA. J. Surg. Res. 103(2), 175–182 (2002).
  Medline CASGoogle Scholar
• 69. Nguyen PD, Tutela JP, Thanik VD et al. Improved diabetic wound healing through topical silencing of p53 is associated with augmented vasculogenic mediators. Wound Repair Regen. 18(6), 553–559 (2010).
  MedlineGoogle Scholar
• 70. Sun N, Ning B, Hansson KM et al. Modified VEGF-A mRNA induces sustained multifaceted microvascular response and accelerates diabetic wound healing. Sci Rep. 8(1), 17509 (2018).
  MedlineGoogle Scholar
• 71. Icli B, Nabzdyk CS, Lujan-Hernandez J et al. Regulation of impaired angiogenesis in diabetic dermal wound healing by microRNA-26a. J. Mol. Cell. Cardiol. 91, 151–159 (2016).
  Medline CASGoogle Scholar
• 72. Khalil AS, Yu X, Umhoefer JM et al. Single-dose mRNA therapy via biomaterial-mediated sequestration of overexpressed proteins. Sci. Adv. 6(27), eaba2422 (2020).
  Medline CASGoogle Scholar
• 73. Randeria PS, Seeger MA, Wang X-Q et al. siRNA-based spherical nucleic acids reverse impaired wound healing in diabetic mice by ganglioside GM3 synthase knockdown. Proc. Natl Acad. Sci. USA 112(18), 5573–5578 (2015).
  Medline CASGoogle Scholar
• 74. Martin JR, Nelson CE, Gupta MK et al. Local delivery of PHD2 siRNA from ROS-degradable scaffolds to promote diabetic wound healing. Adv. Healthc. Mater. 5(21), 2751–2757 (2016).
  Medline CASGoogle Scholar
• 75. Ghatak S, Li J, Chan YC et al. AntihypoxamiR functionalized gramicidin lipid nanoparticles rescue against ischemic memory improving cutaneous wound healing. Nanomedicine 12(7), 1827–1831 (2016).
  Medline CASGoogle Scholar
• 76. Dang CP, Leelahavanichkul A. Over-expression of miR-223 induces M2 macrophage through glycolysis alteration and attenuates LPS-induced sepsis mouse model, the cell-based therapy in sepsis. PLOS ONE 15(7), e0236038 (2020).
  Medline CASGoogle Scholar
• 77. Lan B, Zhang L, Yang L et al. Sustained delivery of MMP-9 siRNA via thermosensitive hydrogel accelerates diabetic wound healing. J. Nanobiotechnol. 19(1), 130 (2021).
  Medline CASGoogle Scholar
• 78. Lin MP, Marti GP, Dieb R et al. Delivery of plasmid DNA expression vector for keratinocyte growth factor-1 using electroporation to improve cutaneous wound healing in a septic rat model. Wound Rep. Regen. 14(5), 618–624 (2006).
  MedlineGoogle Scholar
• 79. Kwon MJ, An S, Choi S et al. Effective healing of diabetic skin wounds by using nonviral gene therapy based on minicircle vascular endothelial growth factor DNA and a cationic dendrimer. J. Gene Med. 14(4), 272–278 (2012).
  Medline CASGoogle Scholar
• 80. Guo R, Xu S, Ma L, Huang A, Gao C. The healing of full-thickness burns treated by using plasmid DNA encoding VEGF-165 activated collagen-chitosan dermal equivalents. Biomaterials 32(4), 1019–1031 (2011).
  Medline CASGoogle Scholar
• 81. Wang S, Yan C, Zhang X et al. Antimicrobial peptide modification enhances the gene delivery and bactericidal efficiency of gold nanoparticles for accelerating diabetic wound healing. Biomater. Sci. 6(10), 2757–2772 (2018).
  Medline CASGoogle Scholar
• 82. Wang P, Huang S, Hu Z et al. In situ formed anti-inflammatory hydrogel loading plasmid DNA encoding VEGF for burn wound healing. Acta Biomater. 100, 191–201 (2019).
  Medline CASGoogle Scholar
• 83. Bitto A, Minutoli L, Galeano MR et al. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Clin. Sci. (Lond) 114(12), 707–718 (2008).
  Medline CASGoogle Scholar
• 84. Chesnoy S, Lee P-Y, Huang L. Intradermal injection of transforming growth factor-beta1 gene enhances wound healing in genetically diabetic mice. Pharm. Res. 20(3), 345–350 (2003).
  Medline CASGoogle Scholar
• 85. Yamamoto A, Kormann M, Rosenecker J, Rudolph C. Current prospects for mRNA gene delivery. Eur. J. Pharm. Biopharm. 71(3), 484–489 (2009).
  Medline CASGoogle Scholar
• 86. Gan L-M, Lagerström-Fermér M, Carlsson LG et al. Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes. Nat. Commun. 10(1), 871 (2019).
  MedlineGoogle Scholar
• 87. Ohki Y, Heissig B, Sato Y et al. Granulocyte colony-stimulating factor promotes neovascularization by releasing vascular endothelial growth factor from neutrophils. FASEB J. 19(14), 2005–2007 (2005).
  Medline CASGoogle Scholar
• 88. Cianfarani F, Tommasi R, Failla CM et al. Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br. J. Dermatol. 154(1), 34–41 (2006).
  Medline CASGoogle Scholar
• 89. Li H, Chang L, Du WW et al. Anti-microRNA-378a enhances wound healing process by upregulating integrin beta-3 and vimentin. Mol. Ther. 22(10), 1839–1850 (2014).
  Medline CASGoogle Scholar
• 90. Tang H, Wang X, Zhang M et al. MicroRNA-200b/c-3p regulate epithelial plasticity and inhibit cutaneous wound healing by modulating TGF-β-mediated RAC1 signaling. Cell Death Dis. 11(10), 1–17 (2020).
  MedlineGoogle Scholar
• 91. Zhou J, Zhao Y, Simonenko V et al. Simultaneous silencing of TGF-β1 and COX-2 reduces human skin hypertrophic scar through activation of fibroblast apoptosis. Oncotarget 8(46), 80651–80665 (2017).
  MedlineGoogle Scholar
• 92. Li J, Ghatak S, El Masry MS et al. Topical lyophilized targeted lipid nanoparticles in the restoration of skin barrier function following burn wound. Mol. Ther. 26(9), 2178–2188 (2018).
  Medline CASGoogle Scholar
• 93. Lucas T, Schäfer F, Müller P, Eming SA, Heckel A, Dimmeler S. Light-inducible antimiR-92a as a therapeutic strategy to promote skin repair in healing-impaired diabetic mice. Nat. Commun. 8(1), 15162 (2017).
  MedlineGoogle Scholar
• 94. Icli B, Wu W, Ozdemir D et al. MicroRNA-615-5p regulates angiogenesis and tissue repair by targeting AKT/eNOS (protein kinase B/endothelial nitric oxide synthase) signaling in endothelial cells. Arterioscler. Thromb. Vasc. Biol. 39(7), 1458–1474 (2019).
  Medline CASGoogle Scholar
• 95. Wang J-M, Tao J, Chen D-D et al. MicroRNA miR-27b rescues bone marrow–derived angiogenic cell function and accelerates wound healing in type 2 diabetes mellitus. Arterioscler. Thromb. Vasc. Biol. 34(1), 99–109 (2014).
  MedlineGoogle Scholar
• 96. Lang H, Zhao F, Zhang T et al. MicroRNA-149 contributes to scarless wound healing by attenuating inflammatory response. Mol. Med. Rep. 16(2), 2156–2162 (2017).
  Medline CASGoogle Scholar
• 97. Saleh B, Dhaliwal HK, Portillo-Lara R et al. Local immunomodulation using an adhesive hydrogel loaded with miRNA-laden nanoparticles promotes wound healing. Small 15(36), 1902232 (2019).
  Google Scholar
• 98. Miscianinov V, Martello A, Rose L et al. MicroRNA-148b targets the TGF-β pathway to regulate angiogenesis and endothelial-to-mesenchymal transition during skin wound healing. Mol. Ther. 26(8), 1996–2007 (2018).
  Medline CASGoogle Scholar
• 99. Wang SY, Kim H, Kwak G et al. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds. Theranostics 10(7), 3240–3253 (2020).
  Medline CASGoogle Scholar
• 100. Li N, Luo H-C, Yang C et al. Cationic star-shaped polymer as an siRNA carrier for reducing MMP-9 expression in skin fibroblast cells and promoting wound healing in diabetic rats. Int. J. Nurs. 9(1), 3377–3387 (2014).
  CASGoogle Scholar
• 101. Ye J, Xie T, Niu Y et al. A potential mechanism for diabetic wound healing: cutaneous environmental disorders. In: Wound Healing - New insights into Ancient Challenges [Internet]. Alexandrescu VA (Ed.). IntechOpen, London (2016).
  Google Scholar
• 102. Kasiewicz LN, Whitehead KA. Lipid nanoparticles silence tumor necrosis factor α to improve wound healing in diabetic mice. Bioeng. Transl. Med. 4(1), 75–82 (2018).
  MedlineGoogle Scholar
• 103. Kasiewicz LN, Whitehead KA. Silencing TNFα with lipidoid nanoparticles downregulates both TNFα and MCP-1 in an in vitro co-culture model of diabetic foot ulcers. Acta Biomater. 32, 120–128 (2016).
  Medline CASGoogle Scholar
• 104. O'Rourke BP, Kramer AH, Cao LL et al. Fidgetin-like 2 siRNA enhances the wound healing capability of a surfactant polymer dressing. Adv. Wound Care 8(3), 91–100 (2019).
  Google Scholar
• 105. Edson J, Kwon YJ. RNAi for silencing drug resistance in microbes toward development of nanoantibiotics. J.Control. Release 189, 150–157 (2014).
  Medline CASGoogle Scholar
• 106. Zhao R, Yan Q, Huang H, Lv J, Ma W. Transdermal siRNA-TGFβ1–337 patch for hypertrophic scar treatment. Matrix Biol. 32(5), 265–276 (2013).
  Medline CASGoogle Scholar
• 107. Tissue Repair Company. Growth factor gene therapy for wound healing. clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT00065663
  Google Scholar
• 108. University of Pennsylvania. Phase I trial to evaluate the safety of platelet-derived growth factor B (PDGF-B) and a limb compression bandage in venous leg ulcers. clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT00000431
  Google Scholar
• 109. Kessler JA, Smith AG, Cha B-S et al. Double-blind, placebo-controlled study of HGF gene therapy in diabetic neuropathy. Ann. Clin. Transl. Neurol. 2(5), 465–478 (2015).
  Medline CASGoogle Scholar
• 110. Losordo DW. VEGF gene transfer for critical limb ischemia. clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT00304837
  Google Scholar
• 111. AnGes USA, Inc. A phase II double-blind, randomized, placebo-controlled study to assess the safety and efficacy of AMG0001 to improve perfusion in critical limb ischemia in subjects who have peripheral ischemic ulcers. clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT00060892
  Google Scholar
• 112. Kessler JA, Shaibani A, Sang CN et al. Gene therapy for diabetic peripheral neuropathy: a randomized, placebo-controlled phase III study of VM202, a plasmid DNA encoding human hepatocyte growth factor. Clin. Transl. Sci. 14(3), 1176–1184 (2021).
  Medline CASGoogle Scholar
• 113. Gurevich I, Agarwal P, Zhang P et al. In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: a phase 1 and 2 trial. Nat. Med. 28(4), 780–788 (2022).
  Medline CASGoogle Scholar